在接受TNF抑制剂治疗的患者中,分散的MDR-TB错过了治疗
Sophie Dam Harmundal Hansen1, Frauke Rudolf2, Nina Schram Gregersen3
1Department of Infectious Diseases, Aarhus Universitetshospital, Aarhus, Denmark sophhs@rm.dk.
BMJ case reports
|September 4, 2024
概括
一名接受瘤亡因子 (TNF) 抑制剂治疗的患者患有多药耐药结核病 (MDR-TB). 这一案例凸显了与TNF抑制剂治疗相关的诊断挑战和风险,特别是针对免疫抑制个体的干扰素-释量测试 (IGRA) 测试.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
背景情况:
- 瘤坏死因子 (TNF) 抑制剂广泛用于炎症状况.
- 这些疗法可以增加机会性感染的风险,包括结核病 (TB).
- 干扰素-释量测试 (IGRA) 测试通常用于结核病查,但可以受到免疫抑制的影响.
研究的目的:
- 为了说明在接受TNF抑制剂的患者中识别结核病的诊断挑战.
- 为了强调在TNF抑制剂治疗期间结核病再激活或新感染的风险增加.
- 突出IGRA测试在免疫抑制患者的局限性以及考虑先前测试结果的重要性.
主要方法:
- 一个以前健康的男性患者的病例报告.
- 详细的临床病史,包括启动TNF抑制剂治疗和肺部症状的发展.
- 对诊断工作的审查,包括连续的IGRA测试和中枢淋巴结的微生物学调查.
主要成果:
- 患者在开始TNF抑制剂治疗两周后出现肺部症状.
- 最初的IGRA测试是负的,尽管在17个月前和同时进行免疫抑制的积极测试.
- 多耐药结核病 (MDR-TB) 的诊断在症状出现八个月后得到证实.
结论:
- 这一案例强调了在使用TNF抑制剂的患者中检测结核病的诊断困难.
- 需要提高人们对使用TNF抑制剂增加结核病风险的认识.
- 进一步了解免疫抑制剂如何影响IGRA测试性能,对于精确的结核病查至关重要.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
Pulmonary Tuberculosis V
174
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174
Pulmonary Tuberculosis III
316
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
316
Pulmonary Tuberculosis I
227
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis II
215
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
215


